Anaptysbio ANAB
NASDAQ ANAB
$56.40 -1.06 (-1.84%)
As of: Sep 4, 2026 · 1:26 PM EDT

Anaptysbio (ANAB) Preferred Dividend Payments (2016)

Anaptysbio's (ANAB) quarterly Preferred Dividend Payments came in at $2.1 million in Q2 2016.

Analysis

Anaptysbio (ANAB) Preferred Dividend Payments (2016) Analysis & Trends

Anaptysbio (ANAB) has 1 years of Preferred Dividend Payments data on file, last reported at $2.1 million in Q2 2016.

  • Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.1 million in Q2 2016, while the trailing twelve-month figure through Sep 2017 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at -$82000.0, down 46.43% from the prior year.
  • Preferred Dividend Payments was little changed at $2.1 million in Q2 2016.
  • In the past five years, Preferred Dividend Payments ranged from a high of $2.1 million in Q2 2016 to a low of $2.1 million in Q2 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Anaptysbio 1.62 Bn 1.33 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 2.14 Mn